辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PFE 辉瑞

交易中 05-01 11:22:49 EDT

24.05

-0.36

-1.49%

最高24.33	最低23.89	成交量1,664万
今开24.33	昨收24.41	日振幅1.78%
总市值1,364亿	流通市值1,361亿	总股本56.71亿
成交额4.01亿	换手率0.29%	流通股本56.62亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"辉瑞","latestPrice":24.0458,"timestamp":1746112968866,"preClose":24.41,"halted":0,"volume":16637245,"delay":0,"floatShares":5661828039,"shares":5671454767,"eps":1.38322,"marketStatus":"交易中","change":-0.3642,"latestTime":"05-01 11:22:49 EDT","open":24.325,"high":24.325,"low":23.89,"amount":400734964.88741004,"amplitude":0.017821,"askPrice":24.05,"askSize":4437,"bidPrice":24.04,"bidSize":557,"shortable":3,"etf":0,"ttmEps":1.38322,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":24.41,"dividendRate":0.070283,"preHourTrading":{"tag":"盘前","latestPrice":24.34,"preClose":24.41,"latestTime":"09:29 EDT","volume":166036,"amount":4030424.2784,"timestamp":1746106199122},"postHourTrading":{"tag":"盘后","latestPrice":24.36,"preClose":24.41,"latestTime":"19:59 EDT","volume":2823570,"amount":68916941.353117,"timestamp":1746057590940},"volumeRatio":1.028202,"impliedVol":0.2974,"impliedVolPercentile":0.556},"requestUrl":"/m/hq/s/PFE","defaultTab":"news","newsList":[{"id":"2532904883","title":"辉瑞4月30日成交额为13.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532904883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532904883?lang=zh_cn&edition=full","pubTime":"2025-05-01 10:22","pubTimestamp":1746066146,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，辉瑞成交额为13.08亿美元，成交额较昨日减少43.87%，当日成交量为5394.17万股。辉瑞于2025年4月30日涨2.61%，报24.41美元，该股过去5个交易日涨9.02%，年初至今跌6.47%，过去60日跌6.83%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-30|13.08亿|-43.87%|5394.17万|#|2025-04-29|23.31亿|80.85%|9854.02万|#|2025-04-28|12.89亿|57.16%|5588.89万|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501102235a46e7041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501102235a46e7041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU0985481810.HKD","LU1066053197.SGD","BK4588","IE00BLSP4452.SGD","LU0456855351.SGD","LU0321505439.SGD","LU0289739699.SGD","PFE","LU0868494617.USD","SG9999001176.USD","BK4599","LU1883839398.USD","IE0002270589.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU1894683264.USD","BK4585","LU0122379950.USD","BK4550","BK4581","LU0058720904.USD","LU0306806265.USD","LU0306807586.USD","SG9999001176.SGD","LU0321505868.SGD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4534","SG9999003800.SGD","LU0234572021.USD","LU0170899867.USD","LU1894683348.USD","SG9999002224.SGD","LU1057294990.SGD","BK4592","LU1066051498.USD","BK4007","SG9999002232.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4568","SG9999011175.SGD","LU0225284248.USD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2532026633","title":"77亿美元，辉瑞又开始省钱了","url":"https://stock-news.laohu8.com/highlight/detail?id=2532026633","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532026633?lang=zh_cn&edition=full","pubTime":"2025-05-01 10:09","pubTimestamp":1746065340,"startTime":"0","endTime":"0","summary":"辉瑞公布2025年第一季度财报，总营收137亿美元，同比下降8%，主要原因是新冠药物Paxlovid销售额下降。研发费用支出也减少12%。辉瑞重申全年收入预计在610亿至640亿美元之间，并宣布新的成本削减计划，预计到2027年节省77亿美元开支。辉瑞通过自动化和人工智能等数字工具以及简化业务流程来实现成本节约，并计划从研发经费中砍掉5亿美元用于重新投资研发管线。在全球医药市场竞争激烈、成本压力上升的背景下，其他跨国药企如百时美施贵宝和赛诺菲也在实施大规模重组和裁员计划以降低成本。这些措施包括优化组织架构、减少层级、提高决策效率和整合职能，以应对行业挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050116092294e9c6ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050116092294e9c6ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002270589.USD","LU0225284248.USD","SG9999002224.SGD","SG9999002232.USD","SG9999003800.SGD","LU0122379950.USD","LU1894683348.USD","BK4581","LU0225771236.USD","IE00B19Z3581.USD","BK4592","BK4550","LU0868494617.USD","BK4588","LU0058720904.USD","LU1057294990.SGD","IE00BLSP4452.SGD","SG9999001176.USD","BK4533","SG9999001176.SGD","LU1066051498.USD","LU0306807586.USD","PFE","IE000M9KFDE8.USD","LU0985481810.HKD","LU0289739699.SGD","LU0456855351.SGD","LU0234572021.USD","SG9999013999.USD","LU0170899867.USD","LU0321505439.SGD","LU1066053197.SGD","SG9999011175.SGD","BK4007","LU1894683264.USD","BK4568","BK4599","SGXZ57979304.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0306806265.USD","LU1883839398.USD","BK4534","BK4585"],"gpt_icon":0},{"id":"2531633056","title":"瑞银：维持Pfizer(PFE.US)评级，由中性调整至中性评级, 目标价由24.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531633056","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531633056?lang=zh_cn&edition=full","pubTime":"2025-04-30 22:12","pubTimestamp":1746022372,"startTime":"0","endTime":"0","summary":"瑞银：维持Pfizer(PFE.US)评级，由中性调整至中性评级, 目标价由24.00美元调整至25.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30221250062023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PFE"],"gpt_icon":0},{"id":"2531774147","title":"减肥药“断腕”、核心药物承压  辉瑞（PFE.US）欲“买买买”加码心脏代谢短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531774147?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:57","pubTimestamp":1745996275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞在2025年第一季度财报中披露，继口服减肥药Danuglipron研发受挫后，公司将通过收购或合作加速布局心脏代谢领域，以弥补产品线空缺。为应对业绩波动，辉瑞升级成本管控计划：在2025年底前实现45亿美元净成本节约的基础上，进一步追加12亿美元节省目标，预计到2027年底累计节省57亿美元。据了解，4月中旬，辉瑞宣布终止GLP-1受体激动剂Danuglipron的研发。辉瑞正面临核心管线断档与成本压力的双重挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002270589.USD","LU0225284248.USD","SG9999002224.SGD","SG9999002232.USD","SG9999003800.SGD","LU0122379950.USD","LU1894683348.USD","BK4581","LU0225771236.USD","IE00B19Z3581.USD","BK4592","BK4550","LU0868494617.USD","BK4588","LU0058720904.USD","LU1057294990.SGD","IE00BLSP4452.SGD","SG9999001176.USD","BK4533","SG9999001176.SGD","LU1066051498.USD","LU0306807586.USD","PFE","IE000M9KFDE8.USD","LU0985481810.HKD","LU0289739699.SGD","LU0456855351.SGD","LU0234572021.USD","SG9999013999.USD","LU0170899867.USD","LU0321505439.SGD","LU1066053197.SGD","SG9999011175.SGD","BK4007","LU1894683264.USD","BK4568","BK4599","SGXZ57979304.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0306806265.USD","LU1883839398.USD","BK4534","BK4585"],"gpt_icon":1},{"id":"2531312703","title":"减肥药“断腕”、核心药物承压辉瑞欲“买买买”加码心脏代谢短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531312703","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531312703?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:57","pubTimestamp":1745996220,"startTime":"0","endTime":"0","summary":"辉瑞在2025年第一季度财报中披露，由于口服减肥药Danuglipron研发受挫，公司将通过收购或合作加速布局心脏代谢领域，以弥补产品线空缺。尽管Q1营收未达预期，但调整后每股收益超预期，公司维持全年盈利指引上限。新冠产品表现不一，Paxlovid收入低于预期，而Comirnaty疫苗超出预期。核心药物如Eliquis销售额下滑。为应对业绩波动，辉瑞升级成本管控计划，预计到2027年底累计节省57亿美元。辉瑞CEO表示将通过内部研发和外部合作构建心脏代谢领域产品矩阵。分析师认为，通过收购或合作快速补充产品线是突破增长瓶颈的关键。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430150811974b363e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430150811974b363e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4239.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU1066053197.SGD","BK4534","LU1066051498.USD","SG9999001176.USD","LU0122379950.USD","BK4581","LU1894683348.USD","LU1894683264.USD","LU0321505868.SGD","BK4592","IE00BBT3K403.USD","BK4550","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4599","LU0306806265.USD","SG9999002232.USD","BK4585","SG9999013999.USD","LU0225284248.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999003800.SGD","SG9999011175.SGD","BK4588","LU1023059063.AUD","LU0306807586.USD","LU0456855351.SGD","BK4533","IE00BLSP4452.SGD","LU0170899867.USD","PFE","LU0321505439.SGD","LU0234572021.USD","BK4007","LU0058720904.USD","LU0868494617.USD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1883839398.USD","LU0225771236.USD","IE0002270589.USD","SGXZ57979304.SGD","BK4568"],"gpt_icon":0},{"id":"2531723794","title":"辉瑞4月29日成交额为23.31亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531723794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531723794?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:21","pubTimestamp":1745979667,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，辉瑞成交额为23.31亿美元，成交额较昨日增加80.85%，当日成交量为9854.02万股。辉瑞于2025年4月29日涨3.21%，报23.79美元，该股过去5个交易日涨5.59%，年初至今跌8.84%，过去60日跌10.29%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|23.31亿|80.85%|9854.02万|#|2025-04-28|12.89亿|57.16%|5588.89万|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102116a46d0133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102116a46d0133&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002232.USD","IE000M9KFDE8.USD","LU0868494617.USD","LU1894683264.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","BK4568","LU0234572021.USD","LU1057294990.SGD","BK4534","PFE","IE00B19Z3581.USD","LU0058720904.USD","LU0456855351.SGD","SG9999002224.SGD","BK4599","LU0289739699.SGD","BK4007","LU0985481810.HKD","SG9999011175.SGD","SG9999013999.USD","LU0170899867.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4588","BK4585","LU0306807586.USD","IE0002270589.USD","BK4533","BK4581","LU1883839398.USD","LU1023059063.AUD","BK4592","IE00BBT3K403.USD","LU0306806265.USD","SG9999001176.SGD","LU0225284248.USD","LU1066053197.SGD","LU1066051498.USD","SG9999003800.SGD","SG9999001176.USD","LU0225771236.USD","LU1894683348.USD","BK4550"],"gpt_icon":1},{"id":"2531757594","title":"美股异动丨辉瑞涨超3% Q1经调整每股盈利远超预期 扩大成本削减力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2531757594","media":"格隆汇APP","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531757594?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:11","pubTimestamp":1745939460,"startTime":"0","endTime":"0","summary":"格隆汇4月29日｜辉瑞(PFE.US)涨超3%，报23.755美元。消息面上，辉瑞周二公布，在加大成本削减力度下，首季净利润同比跌约5%至29.7亿美元，经调整每股盈利92美仙，远高于市场预期的66美仙；营收同比跌8%至137.2亿美元，反映其抗病毒药物Paxlovid的收入减少。公司预计，通过两项成本削减措施，到2027年底将节省约77亿美元。公司维持对2025年全年财报的预期，预计销售额为610亿至640亿美元，惟补充该指引目前不包括与未来关税和贸易政策变化相关的任何潜在影响。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-04-29/doc-ineuwcvn0721829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4550","LU0321505868.SGD","LU0225284248.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0225771236.USD","BK4534","SG9999003800.SGD","IE0002270589.USD","SG9999013999.USD","LU0122379950.USD","BK4581","BK4585","IE00BLSP4239.USD","LU0306807586.USD","LU1894683264.USD","LU0234572021.USD","SG9999002232.USD","LU0058720904.USD","LU0289739699.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","BK4599","BK4588","BK4007","IE00BBT3K403.USD","BK4568","SGXZ57979304.SGD","PFE","SG9999001176.USD","IE00B19Z3581.USD","BK4592","LU0321505439.SGD","LU1066051498.USD","LU0306806265.USD","SG9999002224.SGD","LU0868494617.USD","LU0985481810.HKD","LU1883839398.USD","SG9999001176.SGD","LU0170899867.USD","LU1057294990.SGD","LU0456855351.SGD","BK4533"],"gpt_icon":0},{"id":"1163182552","title":"异动 | 辉瑞盘中涨近3%，辉端首席执行官称与白宫进行了富有成效始的关税讨论","url":"https://stock-news.laohu8.com/highlight/detail?id=1163182552","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163182552?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:50","pubTimestamp":1745938258,"startTime":"0","endTime":"0","summary":"4月29日，截止发稿，辉瑞盘中涨近3%。消息方面：据可靠消息，辉端首席执行官称与白宫进行了富有成效始的关税讨论。同时辉瑞公布，在加大成本削减力度下，首季净利润同比跌约5%至29.7亿美元，经调整每股盈利92美分，远高于市场预期的66美分；营收同比跌8%至137.2亿美元，反映其抗病毒药物Paxlovid的收入减少。公司预计，通过两项成本削减措施，到2027年底将节省约77亿美元。公司维持对2025年全年财报的预期，预计销售额为610亿至640亿美元，惟补充该指引目前不包括与未来关税和贸易政策变化相关的任何潜在影响。","market":"us","thumbnail":"https://static.tigerbbs.com/f2bb9162f10407908b68d91c8d440880","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f2bb9162f10407908b68d91c8d440880"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE"],"gpt_icon":0},{"id":"2531751539","title":"辉瑞(PFE.N)涨近3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531751539","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531751539?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:48","pubTimestamp":1745938133,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4568","BK4588","SG9999013999.USD","SG9999002224.SGD","LU0321505439.SGD","SG9999001176.USD","LU0306806265.USD","IE00BBT3K403.USD","BK4599","LU1066051498.USD","LU1066053197.SGD","PFE","SG9999001176.SGD","IE00BLSP4452.SGD","BK4534","IE00B19Z3581.USD","SG9999002232.USD","BK4007","LU0868494617.USD","LU0170899867.USD","LU0225284248.USD","LU0234572021.USD","IE0002270589.USD","LU0456855351.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","BK4533","SG9999003800.SGD","LU1894683348.USD","LU0122379950.USD","LU0058720904.USD","LU1894683264.USD","SG9999011175.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4550","LU0306807586.USD","LU0289739699.SGD","LU0985481810.HKD","BK4581","LU0321505868.SGD","BK4592","BK4585","LU1023059063.AUD","SGXZ57979304.SGD","LU0225771236.USD"],"gpt_icon":0},{"id":"2531736235","title":"减肥药“折戟”降本力度“救场”，辉瑞(PFE.US)Q1利润超预期但营收下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2531736235","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531736235?lang=zh_cn&edition=full","pubTime":"2025-04-29 20:42","pubTimestamp":1745930578,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，辉瑞公司于周二盘前发布第一季度业绩，本季度加大了成本削减力度，利润超出市场预期。尽管如此，在减肥药愿景破碎及新冠相关产品收入下降的影响下，公司整体营收仍有所下滑。辉瑞于4月14日宣布，由于担心其存在肝损伤风险，将放弃其陷入困境的口服减肥候选药物达格利隆。与其他受贸易政策变化影响的公司不同，辉瑞并未调整其业绩预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"acf37690706a73438284a9e794ae3947","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PFE"],"gpt_icon":1},{"id":"2531357987","title":"辉瑞第一季度营收137.2亿美元 同比下降8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531357987","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531357987?lang=zh_cn&edition=full","pubTime":"2025-04-29 20:33","pubTimestamp":1745929982,"startTime":"0","endTime":"0","summary":"4月29日，辉瑞公布第一季度财报，公司营收达137.2亿美元，较去年同期下降8%，低于市场预期的140.1亿美元。此次业绩下滑主要受药品需求波动及市场竞争加剧影响，公司正调整策略以应对挑战。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042920372094e78aa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":"acf37690706a73438284a9e794ae3947","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042920372094e78aa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE"],"gpt_icon":0},{"id":"2531787736","title":"辉瑞公司一季度营收137.2亿美元，同比下降8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531787736","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531787736?lang=zh_cn&edition=full","pubTime":"2025-04-29 19:49","pubTimestamp":1745927355,"startTime":"0","endTime":"0","summary":"辉瑞公司发布一季度财报。第一季度营收137.2亿美元，同比下降8%；摊薄后每股收益为0.52美元，调整后摊薄后每股收益为0.92美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042919500894e77c0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":"acf37690706a73438284a9e794ae3947","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042919500894e77c0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE"],"gpt_icon":0},{"id":"1159977032","title":"辉瑞一季度营收137.2亿美元略低于预估，维持全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1159977032","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159977032?lang=zh_cn&edition=full","pubTime":"2025-04-29 19:13","pubTimestamp":1745925202,"startTime":"0","endTime":"0","summary":"仍然预测全年营收610亿美元至640亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/99090a3d2e33436ffe2da74357092b17","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/99090a3d2e33436ffe2da74357092b17"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"acf37690706a73438284a9e794ae3947","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"辉瑞一季度营收137.2亿美元略低于预估，维持全年业绩指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE"],"gpt_icon":1},{"id":"2531229914","title":"财报前瞻 | 放弃减肥药赛道 辉瑞(PFE.US)一季度业绩能否有新惊喜？","url":"https://stock-news.laohu8.com/highlight/detail?id=2531229914","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531229914?lang=zh_cn&edition=full","pubTime":"2025-04-29 14:30","pubTimestamp":1745908230,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，制药巨头辉瑞公司将于 4 月 29 日星期二美股盘前公布其第一季度收益结果，投资者主要关注专利到期和药品定价控制等潜在挑战的影响。辉瑞公司于4月14日宣布，由于担心其存在肝损伤风险，将放弃其陷入困境的口服减肥候选药物达格利隆。辉瑞曾一度将其减肥候选药物吹捧为公司的潜在重磅炸弹，但自2023年以来，这一努力接连令人失望，凸显了该公司在开发成功的新药方面所面临的困难。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PFE"],"gpt_icon":1},{"id":"2531294179","title":"由辉瑞一手孵化，现在拟被默克收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2531294179","media":"生物制药小编","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531294179?lang=zh_cn&edition=full","pubTime":"2025-04-28 09:20","pubTimestamp":1745803200,"startTime":"0","endTime":"0","summary":"不出意外，SpringWorks Therapeutics要被德国默克收购了。近日，两家公司已就收购价上达成一致，德国默克将以每股47美元收购SpringWorks，收购总价约为35亿美元，如果后续收购工作顺利，该交易将在下周内完成。由辉瑞一手孵化SpringWorks成立于2017年，是一家专注于癌症和罕见病药物开发的Biotech公司，2019年在纳斯达克证券交易所上市。SpringWorks可以算是由辉瑞一手孵化，SpringWorks的创始人是辉瑞的前研发主管Lara S. Sullivan。这两款药物现在都成功批准上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429073247a46b2267&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429073247a46b2267&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU1057294990.SGD","SG9999015341.SGD","LU1585245621.USD","PFE","LU0265550946.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0234572021.USD","BK4581","LU0965508806.USD","LU1066051498.USD","LU1989772840.SGD","LU0868494617.USD","LU1983299246.USD","LU2324357040.USD","LU1699723380.USD","LU1093756325.SGD","LU0965509101.SGD","MRK","LU1941712348.USD","LU1929549753.HKD","LU0006306889.USD","SG9999015358.SGD","LU2112291526.USD","BK4533","LU0289739699.SGD","LU0985481810.HKD","LU0456855351.SGD","LU2023250504.SGD","LU1934455277.USD","IE00B19Z3581.USD","IE0002270589.USD","IE00B1BXHZ80.USD","BK4516","BK4007","LU1894683264.USD","LU1974910355.USD","LU1894683348.USD","LU0058720904.USD","BK4550","LU1066051225.USD","LU2361045086.USD","SG9999013999.USD","BK4592","LU0170899867.USD","LU1066051811.HKD","LU0321505439.SGD","SG9999001176.SGD","LU2106854487.HKD"],"gpt_icon":1},{"id":"2530497866","title":"诺纳生物合作伙伴辉瑞在2025 AACR年会上公布基于TOP1i靶向人间皮素ADC疗法的临床前数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2530497866","media":"医药魔方","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530497866?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:31","pubTimestamp":1745800285,"startTime":"0","endTime":"0","summary":"诺纳生物，一家致力于前沿技术创新，并为合作伙伴提供涵盖靶点验证和新一代生物大分子药物从发现至临床前研发等Idea to IND完整服务的国际化创新生物技术公司，今日宣布其合作伙伴辉瑞在2025年美国癌症研究协会年会上公布了同类首创基于拓扑异构酶1抑制剂的靶向人间皮素抗体偶联药物PF-08052666的临床前数据。2023年12月14日，辉瑞获得了其全球临床开发和商业化权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428102605a469cf3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428102605a469cf3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683348.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","BK4231","LU0321505439.SGD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4080","BK4568","LU1066053197.SGD","LU1894683264.USD","PFE","SG9999013999.USD","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","LU0234572021.USD","BK4550","BK4534","BK4592","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","BK4533","SG9999003800.SGD","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU0306807586.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1023059063.AUD","LU0225771236.USD","BK4007","BK4588","SG9999002224.SGD","ADC","LU0456855351.SGD"],"gpt_icon":1},{"id":"2530772119","title":"辉瑞4月25日成交额为8.20亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530772119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530772119?lang=zh_cn&edition=full","pubTime":"2025-04-26 10:18","pubTimestamp":1745633897,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，辉瑞成交额为8.20亿美元，成交额较昨日增加3.34%，当日成交量为3584.77万股。辉瑞于2025年4月25日涨0.61%，报22.92美元，该股过去5个交易日涨3.52%，年初至今跌12.18%，过去60日跌13.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426101825a46793a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426101825a46793a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999011175.SGD","LU0306807586.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1894683348.USD","BK4585","BK4592","BK4007","IE000M9KFDE8.USD","SG9999002224.SGD","BK4568","IE00BLSP4452.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","BK4550","BK4534","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1883839398.USD","LU1066051498.USD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999001176.USD","LU0234572021.USD","SG9999001176.SGD","LU0306806265.USD","SG9999002232.USD","LU1894683264.USD","BK4599","IE0002270589.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0170899867.USD","LU0225771236.USD","LU1023059063.AUD","SG9999003800.SGD","BK4533","LU0289739699.SGD","SGXZ57979304.SGD","LU0868494617.USD","BK4588","PFE","LU0456855351.SGD","LU0321505439.SGD"],"gpt_icon":1},{"id":"2530905116","title":"辉瑞英立达 获批国内首个且唯一晚期肾癌一线靶免联合治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2530905116","media":"21经济网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530905116?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:57","pubTimestamp":1745571434,"startTime":"0","endTime":"0","summary":"南方财经4月25日电，辉瑞公司今日宣布，其口服靶向药英立达?（Inlyta?，通用名：阿昔替尼片）于2025年4月22日获得国家药品监督管理局（NMPA）批准，联合特瑞普利单抗用于中高危的不可切除或转移性肾细胞癌（RCC）患者的一线治疗，这也是中国肾癌治疗领域首个且唯一获批的一线靶免联合治疗方案。（21世纪经济报道）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171322a6c7d0d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171322a6c7d0d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505868.SGD","LU1883839398.USD","LU0306807586.USD","LU1057294990.SGD","SG9999013999.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU0122379950.USD","BK4550","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4585","LU1066051498.USD","SG9999011175.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU0170899867.USD","BK4599","SG9999002232.USD","LU0225771236.USD","IE00BLSP4452.SGD","LU0225284248.USD","LU1023059063.AUD","SG9999003800.SGD","IE0002270589.USD","BK4588","BK4533","LU1894683348.USD","IE00BBT3K403.USD","PFE","IE00BLSP4239.USD","LU0306806265.USD","BK4534","LU0868494617.USD","LU0456855351.SGD","BK4568","LU0234572021.USD","LU1894683264.USD","BK4581","BK4592","BK4007","SG9999002224.SGD","LU0289739699.SGD","LU1066053197.SGD","LU0321505439.SGD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2530970288","title":"辉瑞：阿昔替尼获批中国首个且唯一晚期肾癌一线靶免联合治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2530970288","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530970288?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:55","pubTimestamp":1745571304,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0456855351.SGD","BK4599","BK4534","BK4581","BK4592","LU0234572021.USD","LU1057294990.SGD","BK4585","PFE","BK4533","IE00BLSP4239.USD","SG9999002232.USD","LU1883839398.USD","SG9999013999.USD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0306807586.USD","LU0058720904.USD","LU0225284248.USD","LU0321505868.SGD","SG9999011175.SGD","LU0225771236.USD","IE0002270589.USD","LU1894683264.USD","IE00BLSP4452.SGD","BK4568","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","RCC","IE000M9KFDE8.USD","LU0306806265.USD","LU0122379950.USD","LU1066053197.SGD","SG9999003800.SGD","SG9999001176.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683348.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0321505439.SGD","SG9999002224.SGD","LU0985481810.HKD","BK4588","LU0170899867.USD","BK4550"],"gpt_icon":0},{"id":"2530911943","title":"辉瑞4月24日成交额为7.94亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530911943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530911943?lang=zh_cn&edition=full","pubTime":"2025-04-25 10:18","pubTimestamp":1745547492,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，辉瑞成交额为7.94亿美元，成交额较昨日减少30.67%，当日成交量为3500.96万股。辉瑞于2025年4月24日涨1.74%，报22.78美元，该股过去5个交易日涨3.36%，年初至今跌12.71%，过去60日跌14.84%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|#|2025-04-17|12.06亿|44.24%|5407.37万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101820a4662ad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425101820a4662ad2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4588","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU0321505439.SGD","BK4581","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","PFE","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","LU0058720904.USD","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","SG9999002224.SGD","SG9999002232.USD","LU0306807586.USD","BK4568","LU0868494617.USD","BK4533","LU1894683348.USD","LU0321505868.SGD","LU1883839398.USD","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.pfizer.com","stockEarnings":[{"period":"1week","weight":0.0902},{"period":"1month","weight":-0.0367},{"period":"3month","weight":-0.0929},{"period":"6month","weight":-0.131},{"period":"1year","weight":-0.0472},{"period":"ytd","weight":-0.0799}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.001224},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.007083},{"month":3,"riseRate":0.6,"avgChangeRate":0.014714},{"month":4,"riseRate":0.586957,"avgChangeRate":0.018253},{"month":5,"riseRate":0.511111,"avgChangeRate":0.008757},{"month":6,"riseRate":0.488889,"avgChangeRate":0.00215},{"month":7,"riseRate":0.488889,"avgChangeRate":0.01248},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.001198},{"month":9,"riseRate":0.444444,"avgChangeRate":0.003884},{"month":10,"riseRate":0.644444,"avgChangeRate":0.014056},{"month":11,"riseRate":0.688889,"avgChangeRate":0.0279},{"month":12,"riseRate":0.511111,"avgChangeRate":0.009365}],"exchange":"NYSE","name":"辉瑞","nameEN":"Pfizer"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辉瑞,PFE,辉瑞股票,辉瑞股票老虎,辉瑞股票老虎国际,辉瑞行情,辉瑞股票行情,辉瑞股价,辉瑞股市,辉瑞股票价格,辉瑞股票交易,辉瑞股票购买,辉瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}